Given the analogy with the observations of ct-p150Glued in AD brain samples discussed previously, and its predicted formation in the BD research cohort, this finding may provide some indication of the biochemical mechanisms involved in the beneficial effects of therapeutic interventions which negatively regulate IP3 signaling and PKC. Here, PRRT2 is linked to Alzheimer disease.